Certified by Founder Lodge 
                                        
                                        OncoResponse
 
                                                 United States  -  Seattle, Washington 
                                             START UP 
                                                                                    1 Disclosed Funding Rounds $14,000,000
                                            0 Participating Investments
- 
                                                Founded date 
                                                
2016
 - 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad s
                                        
                                        
                                        
                                                                                
                                        
                                                                                | Date | Round | Raised | Participating Investors | 
|---|---|---|---|
| May, 19 ,2023 | Unknown | $14,000,000 | 
                                                
 ARCH Venture Partners
                                                                                
 Canaan
                                                                                
 InterVest Co., LTD
                                                                                
                                                                            
 Takeda Ventures, Inc.
                                                                                
 3B Future Health Fund I & II
                                                                                
                                                                            
 Bering Capital
                                                                                
 RiverVest Venture Partners
                                                                                
Wildcat Discovery Technologies
Leaps by Bayer
ResearchHub
 
                                            
DNTOX
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)